Active ingredientDoxercalciferolCat. No. P-D182-001CAS 54573-75-0Family · Pharmaceutical analytical standards
Doxercalciferol
A synthetic vitamin D2 analogue (1-hydroxyergocalciferol), approved in the United States in 1999 for secondary hyperparathyroidism in dialysis patients: it reduces parathyroid hormone production. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It is a prodrug that already carries the 1-alpha group: the liver turns it into the active form, ercalcitriol, without involving the kidneys, which carry out the last activation step for natural vitamin D.
Go to the active ingredient →Active ingredientDoxercalciferolCat. No. P-D182-001CAS 54573-75-0
Metabolite25-Hydroxy-Doxercalciferol-25-O-GlucuronideCat. No. P-D182-002
Metabolite25-Hydroxy-Doxercalciferol-3-O-GlucuronideCat. No. P-D182-003
Isotopically labelled25-Hydroxy Doxercalciferol-13C-d3Cat. No. P-D182-004
Isotopically labelledDoxercalciferol-13C-d3Cat. No. P-D182-005
Impurity24-Hydroxy DoxercalciferolCat. No. P-D182-006
Impurity25-Hydroxy DoxercalciferolCat. No. P-D182-007CAS 60133-18-8
Impurity26-Hydroxy DoxercalciferolCat. No. P-D182-008
Impuritybeta-DoxercalciferolCat. No. P-D182-009CAS 127516-23-8
ImpurityDihydro-DoxercalciferolCat. No. P-D182-010
ImpurityDoxercalciferol Impurity 1Cat. No. P-D182-011
ImpurityDoxercalciferol Impurity 2Cat. No. P-D182-012CAS 112670-78-7
ImpurityDoxercalciferol Impurity 3Cat. No. P-D182-013
ImpurityDoxercalciferol Impurity 4Cat. No. P-D182-014CAS 111594-58-2
ImpurityDoxercalciferol Impurity 5Cat. No. P-D182-015CAS 115540-27-7
ImpurityDoxercalciferol Impurity 6Cat. No. P-D182-016CAS 115540-28-8
ImpurityPre-DoxercalciferolCat. No. P-D182-017CAS 1818286-63-3
Impuritytrans-DoxercalciferolCat. No. P-D182-018CAS 74007-20-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.